The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Treatable traits: toward precision medicine of chronic airway diseases
Open accessAbstract
Asthma and chronic obstructive pulmonary disease (COPD) are two prevalent chronic airway diseases that have a high personal and social impact. They likely represent a continuum of different diseases that may share biological mechanisms (i.e.endotypes), and present similar clinical, functional, imaging and/or biological features that can be observed (i.e.phenotypes) which require individualised treatment. Precision medicine is defined as “treatments targeted to the needs of individual patients on the basis of genetic, biomarker, phenotypic, or psychosocial characteristics that distinguish a given patient from other patients with similar clinical presentations”. In this Perspective, we propose a precision medicine strategy for chronic airway diseases in general, and asthma and COPD in particular.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationThe sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Self-citationSusceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationMepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411532 · Cited by 1,284
Self-citationAsthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Anderson, G. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61452-x · Cited by 999
Exploring the Effects of Omalizumab in Allergic Asthma: An Analysis of Biomarkers in the EXTRA Study
Hanania, N. A., Wenzel, S., Rosén, K., Hsieh, H.-J., Mosesova, S., Choy, D. F., Lal, P., Arron, J. R., Harris, J. M., & Busse, W. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1414oc · Cited by 901
Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Self-citationA summary of the new GINA strategy: a roadmap to asthma control
Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L.-P., Cruz, A. A., Drazen, J. M., Haahtela, T., Hurd, S. S., Inoue, H., de Jongste, J. C., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00853-2015 · Cited by 788
Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Self-citationPreparing for Precision Medicine
Mirnezami, R., Nicholson, J., & Darzi, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1114866 · Cited by 663
Loscalzo, J., Kohane, I., & Barabasi, A. (2007) · Molecular Systems Biology · doi:10.1038/msb4100163 · Cited by 603
Fabbri, L. M., Romagnoli, M., Corbetta, L., Casoni, G., Busljetic, K., Turato, G., Ligabue, G., Ciaccia, A., Saetta, M., & Papi, A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200203-183oc · Cited by 516
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Laviolette, M., Gossage, D. L., Gauvreau, G., Leigh, R., Olivenstein, R., Katial, R., Busse, W. W., Wenzel, S., Wu, Y., Datta, V., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.020 · Cited by 511
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial
Ryan, N. M., Birring, S. S., & Gibson, P. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60776-4 · Cited by 506
Self-citationMartinez, F. D., & Vercelli, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61536-6 · Cited by 496
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146306 · Cited by 453
Self-citationWagener, A. H., de Nijs, S. B., Lutter, R., Sousa, A. R., Weersink, E. J. M., Bel, E. H., & Sterk, P. J. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205634 · Cited by 429
Self-citationGibson, P. G., McDonald, V. M., & Marks, G. B. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61087-2 · Cited by 394
Self-citationExpert opinion on the cough hypersensitivity syndrome in respiratory medicine
Morice, A. H., Millqvist, E., Belvisi, M. G., Bieksiene, K., Birring, S. S., Chung, K. F., Dal Negro, R. W., Dicpinigaitis, P., Kantar, A., McGarvey, L. P., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00218613 · Cited by 380
Exhaled Nitric Oxide: A Predictor of Steroid Response
Smith, A. D., Cowan, J. O., Brassett, K. P., Filsell, S., McLachlan, C., Monti-Sheehan, G., Herbison, G. P., & Taylor, D. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1498oc · Cited by 371
Powell, H., Murphy, V. E., Taylor, D. R., Hensley, M. J., McCaffery, K., Giles, W., Clifton, V. L., & Gibson, P. G. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60971-9 · Cited by 339
Self-citationBrightling, C. E., Bleecker, E. R., Panettieri, R. A., Bafadhel, M., She, D., Ward, C. K., Xu, X., Birrell, C., & van der Merwe, R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70187-0 · Cited by 315
Travers, J., Marsh, S., Williams, M., Weatherall, M., Caldwell, B., Shirtcliffe, P., Aldington, S., & Beasley, R. (2007) · Thorax · doi:10.1136/thx.2006.066837 · Cited by 310
Self-citationThe association between childhood asthma and adult chronic obstructive pulmonary disease
Tai, A., Tran, H., Roberts, M., Clarke, N., Wilson, J., & Robertson, C. F. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204815 · Cited by 307
Malinovschi, A., Fonseca, J. A., Jacinto, T., Alving, K., & Janson, C. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.007 · Cited by 268
Systems medicine and integrated care to combat chronic noncommunicable diseases
Bousquet, J., Anto, J. M., Sterk, P. J., Adcock, I. M., Chung, K., Roca, J., Agusti, A., Brightling, C., Cambon-Thomsen, A., Cesario, A., et al. (2011) · Genome Medicine · doi:10.1186/gm259 · Cited by 248
Self-citationOrie, N. G. M. (1961) · Medical Entomology and Zoology · Cited by 243
Woodruff, P. G., Agusti, A., Roche, N., Singh, D., & Martinez, F. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60693-6 · Cited by 241
Self-citationFull blood count parameters for the detection of asthma inflammatory phenotypes
Zhang, X. ‐., Simpson, J. L., Powell, H., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., Peters, M. J., et al. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12345 · Cited by 230
Self-citationThe path to personalised medicine in COPD
Agusti, A. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205507 · Cited by 195
Self-citationAgusti, A., Sobradillo, P., & Celli, B. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1414pp · Cited by 186
Self-citationOmalizumab provides long-term control in patients with moderate-to-severe allergic asthma
Buhl, R., Solèr, M., Matz, J., Townley, R., O'Brien, J., Noga, O., Champain, K., Fox, H., Thirlwell, J., & Della Cioppa, G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00278102 · Cited by 179
The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?
Bateman, E. D., Reddel, H. K., van Zyl-Smit, R. N., & Agusti, A. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00254-4 · Cited by 175
Self-citationThe Dutch hypothesis (chronic non-specific lung disease) revisited
Sluiter, H., Koeter, G., de Monchy, J., Postma, D., de Vries, K., & Orie, N. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04040479 · Cited by 163
Update on asthma control in five European countries: results of a 2008 survey
Demoly, P. M., Gueron, B., Annunziata, K., Adamek, L., & Walters, R. D. (2010) · European Respiratory Review · doi:10.1183/09059180.00002110 · Cited by 145
Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?
McDonald, V. M., Higgins, I. J., Wood, L. G., & Gibson, P. G. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202646 · Cited by 139
Self-citationBarriers to new drug development in respiratory disease
Barnes, P. J., Bonini, S., Seeger, W., Belvisi, M. G., Ward, B., & Holmes, A. M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00007915 · Cited by 132
The COPD control panel: towards personalised medicine in COPD
Agustí, A. G. N., & MacNee, W. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202772 · Cited by 121
Ortega, H. G., Li, H., Suruki, R., Albers, F. C., Gordon, D., & Yancey, S. W. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-454oc · Cited by 116
Inflammometry to assess airway diseases
Pavord, I. D., Shaw, D. E., Gibson, P. G., & Taylor, D. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61421-x · Cited by 88
Self-citationMcDonald, V. M., Simpson, J. L., Higgins, I., & Gibson, P. G. (2010) · Age and Ageing · doi:10.1093/ageing/afq134 · Cited by 88
Self-citationHonkoop, P., Loijmans, R. J. B., Termeer, E. H., Snoeck-Stroband, J. B., van den Hout, W. B., Bakker, M. J., Assendelft, W. J., ter Riet, G., Sterk, P. J., Schermer, T. R., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.016 · Cited by 81
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
Vanfleteren, L. E. G. W., Kocks, J. W. H., Stone, I. S., Breyer‐Kohansal, R., Greulich, T., Lacedonia, D., Buhl, R., Fabbri, L. M., Pavord, I. D., Barnes, N. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203602 · Cited by 80
Self-citationAgustí, A. G. N., Antó, J. M., Auffray, C., Barbé, F., Barreiro, E., Dorca, J., Escarrabill, J., Faner, R., Furlong, L. I., García‐Aymerich, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1935pp · Cited by 73
Pa, V., & Pride, N. B. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04040490 · Cited by 67
Prescribing trends in asthma: a longitudinal observational study
Turner, S., Thomas, M. D., von Ziegenweidt, J., & Price, D. B. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2008.140681 · Cited by 57
Self-citationVariability of hospital resources for acute care of COPD patients: the European COPD Audit
López-Campos, J. L., Hartl, S., Pozo-Rodríguez, F., & Roberts, C. M. (2013) · European Respiratory Journal · doi:10.1183/09031936.00074413 · Cited by 55
Agustí, A. G. N. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-055aw · Cited by 55
Network Analysis in the Investigation of Chronic Respiratory Diseases. From Basics to Application
Díez, D., Agustí, A. G. N., & Wheelock, C. E. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0421pp · Cited by 52
Companion diagnostics: the key to personalized medicine
Jørgensen, J. T. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002470 · Cited by 51
Developing New Drug Treatments in the Era of Network Medicine
Silverman, E. K., & Loscalzo, J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.207 · Cited by 50
McDonald, V. M., Higgins, I., Simpson, J. L., & Gibson, P. G. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00025 · Cited by 39
Self-citationThe asthmas in 2015 and beyond: a Lancet Commission
Bush, A., Kleinert, S., & Pavord, I. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60654-7 · Cited by 33
Self-citationInhaled steroids in COPD: when should they be used?
Agustí, A. G. N., & Fabbri, L. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70227-9 · Cited by 32
Ritchie, M. D., de Andrade, M., & Kuivaniemi, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00104 · Cited by 28
Caberlotto, L., & Lauria, M. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.975214 · Cited by 26
Batrla, R., & Jordan, B. W. M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12754 · Cited by 19
Cited by
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,303
Self-citationPractitioner’s guide to latent class analysis: Methodological considerations and common pitfalls
Sinha, P., Calfee, C. S., & Delucchi, K. L. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004710 · Cited by 1,204
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 827
Self-citationTowards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citation
Metadata
- Authors
- Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S., Humbert, M., Jones, P., Gibson, P. G., Vestbo, J., Beasley, R., & Pavord, I. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2016-01-31
- Volume
- 47
- Issue
- 2
- Pages
- 410-419
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2263808047
- Cited by
- 1,083
- References
- 68
- FWCI
- 80.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.